Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2409623
Max Phase: Preclinical
Molecular Formula: C20H28F3N3O4
Molecular Weight: 317.43
Molecule Type: Small molecule
Associated Items:
ID: ALA2409623
Max Phase: Preclinical
Molecular Formula: C20H28F3N3O4
Molecular Weight: 317.43
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(O)C(F)(F)F.c1ncc([C@@H]2C[C@H]2CCN2CCOCC2)cc1OC[C@@H]1CCN1
Standard InChI: InChI=1S/C18H27N3O2.C2HF3O2/c1-3-20-16(1)13-23-17-9-15(11-19-12-17)18-10-14(18)2-4-21-5-7-22-8-6-21;3-2(4,5)1(6)7/h9,11-12,14,16,18,20H,1-8,10,13H2;(H,6,7)/t14-,16+,18-;/m1./s1
Standard InChI Key: VFCGCLHYFQQSIR-RLOSDUHESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 317.43 | Molecular Weight (Monoisotopic): 317.2103 | AlogP: 1.65 | #Rotatable Bonds: 7 |
Polar Surface Area: 46.62 | Molecular Species: BASE | HBA: 5 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 9.79 | CX LogP: 0.75 | CX LogD: -2.03 |
Aromatic Rings: 1 | Heavy Atoms: 23 | QED Weighted: 0.83 | Np Likeness Score: -0.43 |
1. Zhang HK, Yu LF, Eaton JB, Whiteaker P, Onajole OK, Hanania T, Brunner D, Lukas RJ, Kozikowski AP.. (2013) Chemistry, pharmacology, and behavioral studies identify chiral cyclopropanes as selective α4β2-nicotinic acetylcholine receptor partial agonists exhibiting an antidepressant profile. Part II., 56 (13): [PMID:23734673] [10.1021/jm400510u] |
Source(1):